The part played by genetic factors in the aetiopathogenesis of rheumatoid arthritis eRA) has been the subject of previous study. In particular, there have been a number of twin Studies, notably those evaluating one or more pairs of twins,l-3 and the two population based Studies by the Arthritis and Rheumatism Council 9 and Abo et al. 10 Although a combination of epidemiological surveys, family and twin Studies, and observations on the relation between disease and HLA genotype has resulted in a better undemanding of RA, nevertheless, the relative conttibution of genetic and environmental factors remains obscure. Previous Studies have been limited by one or more factors including small sample size, highly selected patients, and a lack of adequate diagnostic information. To further investigate the actiopathogc:ncsis of RA, we have conducted a study of twins with RA in Australia. In COntI2St with previous Studies, we have used a large population based sample and applied strict criteria in defining, the presencc of RA.
Patients aad methods

SUBJECIS
The study used the Australian National Health rheumatologist (NBl. In those instaDCCS where the clinical protile questionnaire was not rerurned.
• "",n .. 1 .,i ~B!~d :nrcr-. 29%. Clinical assessment can be approached in a varietY of ways using chart review, individual history, and physical examination, interview of attending medical staff, and review of radiographs and serological results. The long follow up, the high mobilitY of modem populations, and the wide geographical dispersal of study subiects all hamper the collection of data which are accurate and complete. The twins are widdy distributed throughout Australia; some are in urban centres but others are in rural areas, and it was possible for the stUdy rheumatologist to personally interview and e:umine only twO subiects of one of the concordant pairs. Nevertheless, in this stUdy we have used a varietY of tcclmiques to obtain essential diagnostic information. Anv effects of lost follow up (non-teSpODSe bias) ~ specuJarive. Bias can be considered in twO dimensions: allltPlitude and direction. .\ number of factOrs suggest tiw any non-rcspo11Se bias was probably small in ~tude: l:aJ the prevaience of RA in our study· O·~o; was very • similar to that in the Australian Bureau of Statistics population based survey (0·32%); (b) loss to follow up was greatest in the: oldest c:ohotts-dw is beyond the time at which most patients destined to develop RA would have dcdared themselves; (e) the loss to follow-up of patients between 1980 and 1990 from the RA sample was c:zaaly rep1icau:d in the total sample; and (4) the mean age of onset ofRA (39 years) in this group of patients was close to the usually cited mean age of onset (40 years).16 17 Wah respect to the direction of operation, early mortality in patients with severe RA, or high geographical mobility in patients with mild or remittent RA could, respectively. inaease or decrease the observed rates for concordance and prevalence. Given that any non-response bias was probably small in magnitude, however, its direction of operation is less importanL Our stUdy differs from that of the Finnish Twin Study in that record linkage was not used or indeed available. Instead, this study was based on a large voluntary nationwide registry. Furthermore, in the F"mnish study a diagnosis of RA which qualified a patient for free drugs was based on the two criteria of notification of diagnosis by an attending doctor and approval by an expert adviser. Although the error ass0-ciated with this method of determination has not been clearly defined, it could be considerable.
Whether or DOt that diagnosis was based on the 1959 ARA criteria J5 is uncertain from the published. report, but the study certainly predated. the 1981 ARA criteria which we have used in this stUdy. Furthermore, in the Australian survey the ARA criteria were exactly applied. following personal contact of the study rheumatologist with patients with RA, the attending general practitioner, and any rheumatologist or orthopaedic surgeon who bad been consulted. In two instances the respondents were personally intervicwed and examined. by the study rheumatologist. Even for patients without RA, in ambiguous instances the patient was contacted. and, where necessary, the opinion of medical staff sought. As a result, we believe that the verification of diagnosis has been more rigorous in this than previous studies.
Our data provide a number of interesting insights into RA. In the first instance it is clear that the seJf-reporting of RA is unsatisfactory and associated with an ememely bigh false positive rate. The accuracy of diagnosis is greater when the corwin confirms the diagnosis reported by the affected twin than when the diagnosis is unconfirmed or negative (~..ohen's x=0·2%, 95% CI=O·l1 to O·41). As noted previously, the A TR questionnaire contained items for self reporting on the health status of 'sdf', 'corwin', and 'other family members'. Such a contingency offers obvious advantageS given the false positive and to a lesser c:xlent the false negative rate that attend self reporting of diagnosis. In particular, this contingency results in increased specificity of diagnosis. It is essential. however, in population based studies that the diagnosis is confirmed using evidence from experts. serology. and radiographs which can be rated. against an international standard. 
